Procurement Summary
Country : Brazil
Summary : Price Registration for Future and Eventual Acquisition of Basic, Injectable and Complementary Medicines, Meeting the Demands of Municipalities Associated with Cisalv.
Deadline : 08 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 99177584
Document Ref. No. : 90008/2024
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price Registration for future and eventual acquisition of basic, injectable and complementary medicines meeting the demands of municipalities associated with CISALV.
UASG Code: 927658
Notice from: 03/21/2024 at 08:00 to 12:00 pm and from 1:00 pm to 5:00 pm
Entr19981d172c851bd4e8a1788d5726c2d3time of the Proposal: from 03/21/2024 at 08:00
8-HYDROxYQUINOLINE BORATE, PRESENTATION ASSOCIATED WITH TRIETHANOLAMINE, CONCENTRATION 0.4MG 140MG/ML, INDICATION ENT SOLUTION
Quantity: 800
ACEBROPHYLLINE, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 800
ACEBROPHYLLINE, CONCENTR19981d172c851bd4e8a1788d5726c2d3ACTION 5 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 800
ACETYLCYSTEINE, DOSAGE 20 MG/ML, INDICATION SYRUP
Quantity: 5000
ACETYLCYSTEINE, CONCENTRATION 40 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 5000
ACETYLSALICYLIC ACID, DO SAGEM 100 MG, BUFFERED USE TYPE
Quantity: 108000
ACETYL ACID19981d172c851bd4e8a1788d5726c2d3SALICYLIC, DOSAGE 100 MG, BUFFERED USE TYPE
Quantity: 12000
ASCORBIC ACID, DOSAGE 1 G, EFFERVESCENT TABLET USE TYPE
Quantity: 8000
ASCORBIC ACID, DOSAGE 100 MG/ML, INJECTABLE USE TYPE
Quantity: 800
T ACID RANExAMIC, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity19981d172c851bd4e8a1788d5726c2d3ade: 600
ZOLEDRONIC ACID, CONCENTRATION 4 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 200
AMBROxOL, HYCLORYDRATE SALT COMPOSITION, CONCENTRATION 3 MG/ML, PHARMACEUTICAL SYRUP FORM
Quantity: 3500
AMBROxOL, CL SALT COMPOSITION OHYDRATE, CONCENTRATION 6 MG/ML, PHARMACEUTICAL FORM SYRUP
Quan19981d172c851bd4e8a1788d5726c2d3Quantity: 3500
AMICACIN SULFATE, DOSAGE 250 MG/ML, INJECTION SOLUTION INJECTABLE
Quantity: 1000
AMILORIDE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH CHLORTHALIDONE, CONCENTRATION 5 MG 25 MG
Quantity: 4000
AMOxICILLIN, ACTIVE PRINCIPLE ASSOCIATED WITH CLAV POTASSIUM ULANATE, CONCENTRATION 1G 200MG, APRES19981d172c851bd4e8a1788d5726c2d3INJECTABLE ENTATION
Quantity: 800
ANLODIPINE BESYLATE, ...
Documents
Tender Notice